P3 Health Partners Inc. (PIII) EBITDA Margin (2021 - 2026)
P3 Health Partners' (PIII) quarterly EBITDA Margin came in at 39.98% in Q4 2025, down 262.0% YoY from 24.68% in Q4 2024, and down 212.16% on a QoQ basis from 12.81% in Q3 2025.
P3 Health Partners Inc. (PIII) EBITDA Margin (2021 - 2026) Analysis & Trends
P3 Health Partners (PIII) has 5 years of EBITDA Margin data on file, last reported at 39.98% in Q4 2025.
- Quarterly EBITDA Margin fell 262.0% year-over-year to 39.98% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 18.53% (up 285.0% YoY) and the FY2025 annual result came in at 18.53%, up 285.0% from the prior year.
- EBITDA Margin slipped to 39.98% in Q4 2025, from 12.81% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 6.39% in Q2 2023 to a low of 338.53% in Q2 2022.
- A 5-year average of 42.87% and a median of 16.66% in 2021 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin sank 32138 bps — and 2023, when it surged 33214 bps.
- Tracing PIII's EBITDA Margin over 5 years: stood at 12.33% in 2021, then sank by 1585 bps to 207.79% in 2022, then jumped by 91 bps to 18.53% in 2023, then slumped by 102 bps to 37.36% in 2024, then fell by 7 bps to 39.98% in 2025.
- The last three EBITDA Margin figures came in at 39.98% (Q4 2025), 12.81% (Q3 2025), and 9.59% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.67% |
| Dec 31, 2025 | -39.98% |
| Sep 30, 2025 | -12.81% |
| Jun 30, 2025 | -9.59% |
| Mar 31, 2025 | -10.21% |
| Dec 31, 2024 | -37.36% |
| Sep 30, 2024 | -29.55% |
| Jun 30, 2024 | -8.26% |
| Mar 31, 2024 | -11.28% |
| Dec 31, 2023 | -18.53% |
| Sep 30, 2023 | -11.73% |
| Jun 30, 2023 | -6.39% |
| Mar 31, 2023 | -16.16% |
| Dec 31, 2022 | -207.79% |
| Sep 30, 2022 | -24.17% |
| Jun 30, 2022 | -338.53% |
| Mar 31, 2022 | -19.07% |
| Dec 2, 2021 | -12.33% |
| Sep 30, 2021 | -18.01% |
| Jun 30, 2021 | -17.15% |